Status:
COMPLETED
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
Lead Sponsor:
Sheikh Zayed Federal Postgraduate Medical Institute
Conditions:
Neonatal Sepsis
Omphalitis
Eligibility:
All Genders
1-10 years
Phase:
PHASE2
Brief Summary
Introduction: Neonatal sepsis in one of the leading cause of death in developing countries. Umbilical cord care is important as it may lead to infection. Topical treatment can help to reduce the chanc...
Detailed Description
Introduction: Neonatal sepsis in one of the leading causes of death in neonates in developing countries. Infection of the umbilical cord often leads to infection in the blood. World Health Organizati...
Eligibility Criteria
Inclusion
- Term neonates of either gender born via cesarean section or spontaneous vaginal delivery at Shaikh Zayed Hospital after taking informed consent of parents.
- Antiseptic agent started from 1st day of life \& up to 10 days continued without missing dose
Exclusion
- Newborns with congenital defects or cord anomalies.
- Laboratory or clinical evidence of sepsis.
- Preterm newborns
- Newborns having very low birth weight \<1.5 kg
- Any evidence of asphyxia during birth.
Key Trial Info
Start Date :
September 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06002295
Start Date
September 12 2020
End Date
November 19 2021
Last Update
August 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheikh Zayed Federal Postgraduate Medical Institute
Lahore, Punjab Province, Pakistan, 54500